Core Viewpoint - Rosen Law Firm is reminding investors who purchased Plug Power Inc. securities between January 17, 2025, and November 13, 2025, of the April 3, 2026, deadline to become lead plaintiffs in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Plug Power securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by April 3, 2026, to serve as lead plaintiff [2] - The lawsuit alleges that defendants made false or misleading statements regarding the availability of funds from the U.S. Department of Energy and the construction of hydrogen production facilities, leading to investor damages when the truth was revealed [4] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting that many firms issuing notices may lack the necessary experience [3] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company, and has consistently ranked highly in securities class action settlements since 2013 [3] - In 2019, Rosen Law Firm secured over $438 million for investors, and its founding partner was recognized as a leading figure in the plaintiffs' bar [3]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased BlackRock TCP Capital Corp. securities between November 6, 2024, and January 23, 2026, of the upcoming lead plaintiff deadline on April 6, 2026, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought BlackRock TCP securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - To serve as lead plaintiff, individuals must file a motion with the Court by April 6, 2026 [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been recognized as a leader in the field of securities class action litigation [4]. Group 3: Case Allegations - The lawsuit alleges that defendants made materially false and misleading statements regarding BlackRock TCP's business and operations, including issues with investment valuations and portfolio restructuring [5]. - Specific claims include that BlackRock TCP's unrealized losses were understated and net asset value was overstated, leading to misleading positive statements about the company's prospects [5].

Group 1 - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by officers and directors of Charter Communications, Inc. [1] - A federal securities lawsuit alleges that insiders at Charter Communications misrepresented the impact of the end of the ACP program, which affected Internet customer declines and revenue [2] - The lawsuit claims that Charter failed to execute broader operations to mitigate the impact of the ACP ending, leading to greater risks on business plans and earnings growth than reported [2] Group 2 - The company allegedly had no reasonable basis for optimistic statements regarding its operations and long-term EBITDA growth [2] - Shareholders who purchased CHTR stock prior to July 26, 2024, are encouraged to contact Kuehn Law for potential legal action [3] - Kuehn Law covers all case costs for its investor clients, emphasizing the importance of shareholder participation in maintaining market integrity [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Ardent Health, Inc. securities between July 18, 2024, and November 12, 2025, of the March 9, 2026, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Ardent Health securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [2] - The lead plaintiff must file a motion with the Court by March 9, 2026, to represent other class members in the litigation [2] Group 2: Law Firm Credentials - Rosen Law Firm specializes in securities class actions and has a strong track record, including the largest securities class action settlement against a Chinese company [3] - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [3] - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [3] Group 3: Case Allegations - The lawsuit alleges that Ardent Health made misrepresentations regarding its accounts receivable and the processes used to determine their collectability [4] - Defendants claimed to employ an active monitoring process for accounts receivable, but the actual method involved a 180-day cliff for reserving accounts, leading to inflated reported amounts [4] - The firm also alleged that Ardent Health did not maintain sufficient professional malpractice liability insurance, which was inadequate to cover claims due to rising social inflationary pressures in medical malpractice cases [4]

Core Viewpoint - Rosen Law Firm is reminding former stockholders of Smartsheet Inc. about a class action lawsuit related to the company's January 2025 sale to a consortium led by Blackstone, Vista Equity Partners, and Platinum Falcon, with a lead plaintiff deadline of February 24, 2026 [1] Group 1: Class Action Details - Former Smartsheet stockholders may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 24, 2026 [1] - The complaint alleges that Smartsheet's solicitation of stockholder approval for the Buyout involved a false and misleading Proxy statement that mischaracterized the company's financial performance [1] Group 2: Allegations Against Defendants - The defendants are accused of intentionally portraying Smartsheet's quarterly earnings negatively and emphasizing a fabricated financial metric to solicit approval for the Buyout [1] - Mark P. Mader, a defendant, is alleged to have failed in his disclosure duties by not exercising reasonable care [1] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked highly for settlements since 2013 [1] - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [1]

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by officers and directors of Integer Holdings Corporation (NYSE: ITGR) related to shareholder interests [1]. Group 1: Allegations of Misrepresentation - A federal securities lawsuit claims that insiders at Integer misrepresented the company's competitive position in the expanding EP manufacturing market [2]. - The lawsuit alleges that Integer overstated its visibility into customer demand while actually experiencing a decline in sales for two of its EP devices [2]. - Integer is accused of mischaracterizing its EP devices as a long-term growth driver for its C&V segment, leading to materially false and misleading statements about the company's business and prospects [2].

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Avantor, Inc. related to misrepresentation of the company's competitive positioning and operational challenges [1][2]. Group 1: Allegations of Misrepresentation - A federal securities lawsuit claims that insiders at Avantor misrepresented the company's competitive positioning, indicating it was weaker than publicly stated [2]. - The lawsuit also alleges that Avantor faced negative impacts from increased competition, which were not disclosed to shareholders [2]. - As a result of these issues, the representations regarding Avantor's business, operations, and future prospects were deemed materially false and misleading [2]. Group 2: Shareholder Actions - Shareholders who purchased AVTR shares prior to March 5, 2024, are encouraged to contact Kuehn Law for potential legal action, as the firm covers all case costs [3]. - The firm emphasizes the importance of shareholder participation in maintaining the integrity and fairness of financial markets [4].

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of CarMax, Inc. related to misrepresentation of the company's growth prospects [1][2]. Group 1: Investigation Details - The investigation is focused on whether CarMax insiders misrepresented or failed to disclose critical information regarding the company's growth, which was influenced by temporary factors such as customer speculation about tariffs [2]. - Allegations suggest that statements made about CarMax's business operations and future prospects were materially false and misleading, lacking a reasonable basis during relevant times [2]. Group 2: Shareholder Participation - Shareholders who purchased KMX shares prior to June 20, 2025, are encouraged to contact Kuehn Law for potential legal action, as there may be limited time to enforce their rights [3]. - The firm covers all case costs and does not charge its investor clients, emphasizing the importance of shareholder involvement in maintaining market integrity [4].

Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Skye Bioscience, Inc. related to misrepresentation of the company's product effectiveness and prospects [1][2]. Group 1: Legal Investigation - Kuehn Law is looking into whether Skye Bioscience's insiders misrepresented the effectiveness of nimacimab, leading to overstated clinical, regulatory, and commercial prospects [2]. - The investigation is prompted by a federal securities lawsuit alleging that public statements made by Skye Bioscience were materially false and misleading [2]. Group 2: Shareholder Participation - Shareholders who purchased SKYE shares prior to November 4, 2024, are encouraged to contact Kuehn Law to enforce their rights, as there may be limited time to act [3]. - Kuehn Law covers all case costs and does not charge its investor clients, emphasizing the importance of shareholder involvement in maintaining market integrity [4].

Group 1 - Kuehn Law is investigating potential breaches of fiduciary duties by officers and directors of StubHub Holdings, Inc. [1] - A federal securities lawsuit alleges that insiders at StubHub misrepresented or failed to disclose significant changes affecting the company's cash flow and vendor payments [2] - The lawsuit claims that these misrepresentations led to materially misleading reports on free cash flow and positive statements about the company's business prospects [2] Group 2 - Shareholders who purchased STUB before October 1, 2025, are encouraged to contact Kuehn Law for potential legal action [3] - Kuehn Law covers all case costs and does not charge clients, emphasizing the importance of timely action for shareholders [3] - The firm highlights the significance of shareholder participation in maintaining the integrity of financial markets [4]